Fri, 30 Oct 2026
06:57:09 am
Rudransh Sangwan
Published at: October 30, 2026, 4:08 AM
Synopsis
Motilal Oswal Q2 FY27 results show net profit rising 198% to ₹1,080 crore, revenue increasing 64% to ₹3,040 crore and EBITDA margin reaching 60.37%.

Motilal Oswal Financial Services reported a 198% year-on-year increase in consolidated net profit to ₹1,080 crore in Q2 FY27. Revenue rose 64% to ₹3,040 crore, while EBITDA increased to ₹1,840 crore.
| Financial Metric | Q2 FY27 | Year-on-Year Growth |
|---|---|---|
| Revenue | ₹3,040 crore | +64% |
| EBITDA | ₹1,840 crore | — |
| EBITDA Margin | 60.37% | Up from 45.42% |
| Net Profit | ₹1,080 crore | +198% |
| Operating PAT | ₹718 crore | +29% |
The sharp increase in reported net profit was partly driven by gains from the company's treasury portfolio. Operating profit after tax (Operating PAT) grew at a more moderate 29% year-on-year.
Asset and Private Wealth Management was the largest contributor to operating profit, accounting for 43% of the total.
The company's asset management business reported total assets under management of approximately ₹2.23 lakh crore, up 26% year-on-year. Private Wealth Management AUM increased 58% to around ₹3 lakh crore.
Motilal Oswal received SEBI approval to operate as a custodian of securities, with operations expected to begin in Q4 FY27. Its treasury book value increased 27% year-on-year to ₹11,346 crore.
The company also reported that annual recurring revenue accounted for 66% of total revenue, reflecting a growing contribution from recurring business.
| Period | Return |
|---|---|
| 1 day | -0.05% |
| 5 days | +0.93% |
| 1 month | -1.01% |
| 6 months | +25.63% |
| 1 year | -2.15% |
| 5 years | +330.69% |
Key takeaway: Motilal Oswal delivered strong revenue and reported profit growth in Q2 FY27, supported partly by treasury gains and continued expansion in its wealth management businesses.

Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.

Bliss GVS Pharma Q2 FY27 results show revenue rising 37.3% to ₹261.13 crore, EBITDA jumping 161.4% and net profit increasing 196%.

Alivus Life Sciences Q2 FY27 results show net profit rising 51.3% to ₹196.8 crore, revenue growing 16% to ₹682 crore and EBITDA margin reaching 38.

Thyrocare Q2 FY27 revenue rose 25.1% to ₹270.81 crore, while net profit fell 66.9% to ₹15.89 crore amid a ₹44.98 crore impairment loss.

Patel Retail will invest ₹2 crore to add 20,000 sq ft to its Ambernath distribution centre, increasing covered area to 84,000 sq ft.

Shadowfax Technologies Q2 FY27 results show revenue growth of 56.6% to ₹1,537.70 crore and a 422% jump in net profit to ₹67.95 crore.